Condition

Solid Malignancies clinical trials and research

• 8Clinical trials
• 7Countries

Newest Solid Malignancies clinical trials

All recruiting trials (8)

• Theranostic PET for target validation and tumor detection in solid cancers

  This is an observational effort to see how theranostic PET scans reflect tumor targets and help with staging, restaging, and treatment planning for adults with solid cancers.

  Recruiting University Hospital, Essen · Essen · NCT07664410

• Cold exposure with PD-1/PD-L1 immunotherapy in solid tumors

  This phase 1 study tests whether adding controlled cold exposure to standard PD-1/PD-L1 therapy is safe and feasible in adults with solid tumors.

  Recruiting Phase 1 West China Hospital · Chengdu, Sichuan · NCT07538479

• 177Lu-IM-3050, a targeted radiopharmaceutical for advanced solid tumors.

  This trial will test whether the targeted radioactive drug 177Lu-IM-3050 is safe and can shrink FAP-positive advanced solid tumors in adults who have not responded to standard treatments.

  Recruiting at 5 sites Phase 1 Immunome, Inc. · Dothan, Alabama and 4 other locations · NCT07505771

• CMAB017 for safety and tolerability in advanced solid tumors

  This trial tests whether the experimental antibody CMAB017 is safe and tolerated in adults with advanced solid tumors who have exhausted or declined standard treatments.

  Recruiting Phase 1 Taizhou Mabtech Pharmaceutical Co.,Ltd · Shanghai · NCT06933069

• Testing IM-1021 for advanced cancer treatment

  This study is testing a new treatment called IM-1021 to see if it can safely help people with advanced cancer feel better.

  Recruiting at 24 sites Phase 1 Immunome, Inc. · Duarte, California and 23 other locations · NCT06823167

• SKB571 for adults with advanced solid tumors

  This first-in-human Phase 1 test gives SKB571 to adults with advanced or metastatic solid tumors to see if it is safe, how the body handles it, and whether it shows anti-tumor activity.

  Recruiting at 13 sites Phase 1 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Guangzhou, Guangdong and 14 other locations · NCT06725381

• Exploring a new imaging tracer for cancer detection

  This study is testing a new imaging tracer to see if it can help doctors find cancer in patients with tumors using special scans.

  Recruiting Affiliated Hospital of Jiangnan University · Wuxi, Jiangsu · NCT06684028

• Testing CT7439 for treating solid tumors

  This study is testing a new drug called CT7439 to see if it is safe and effective for people with solid tumors.

  Recruiting at 6 sites Phase 1/2 Carrick Therapeutics Limited · Dallas, Texas and 5 other locations · NCT06600789

Related topics

Quick answers

How many Solid Malignancies clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in China (4 trials), United States (3 trials), Denmark (1 trial), France (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 5, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →